Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients
2002 | journal article
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Jacob, Sonja, Burkhard Poeggeler, Jochen H. Weishaupt, Anna-Leena Sirén, Rüdiger Hardeland, Mathias Bähr, and Hannelore Ehrenreich. "Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients." Journal of Pineal Research 33, no. 3 (2002): 186-187. https://doi.org/10.1034/j.1600-079X.2002.02943.x.
